Results for tag: "Lofexidine"

Lofexidine is a medication used to treat symptoms of opioid withdrawal. It is a centrally acting alpha-2 adrenergic agonist, and is the first non-opioid medication approved by the US Food and Drug Administration (FDA) for the treatment of opioid withdrawal. It is used to reduce the severity of opioid withdrawal symptoms, such as anxiety, agitation, muscle aches, sweating, and runny nose. It is also used to reduce the craving for opioids. Lofexidine is available in the form of tablets, capsules, and oral solutions. It is marketed by several pharmaceutical companies, including US WorldMeds, Hikma Pharmaceuticals, and Mylan. It is also available as a generic drug. The lofexidine market is expected to grow due to increasing prevalence of opioid addiction and increasing awareness about the use of non-opioid medications for opioid withdrawal. The increasing number of clinical trials and the approval of lofexidine by the FDA are also expected to drive the market growth. Some of the major companies in the lofexidine market are US WorldMeds, Hikma Pharmaceuticals, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more